Skip to content

5-HT2A/5-HT2C Receptor Pharmacology and Intrinsic Clearance of N-Benzylphenethylamines Modified at the Primary Site of Metabolism.

Sebastian Leth-Petersen, Ida N Petersen, Anders A. Jensen, Christoffer Bundgaard, Mathias Bæk, Jan Kehler, Jesper L. Kristensen

ACS Chemical Neuroscience November 16, 2016 DOI: 10.1021/acschemneuro.6b00265 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Peer reviewed
Topics Serotonin
Keywords 5-ht2a receptor agonists Phenethylamines Hallucinogens Microsomal stability
Key points All novel analogues of 25B-NBOMe had an intrinsic clearance above 1.3 L/kg/h, predictive of high first-pass metabolism.

Abstract

The toxic hallucinogen 25B-NBOMe is very rapidly degraded by human liver microsomes and has low oral bioavailability. Herein we report on the synthesis, microsomal stability, and 5-HT2A/5-HT2C receptor profile of novel analogues of 25B-NBOMe modified at the primary site of metabolism. Although microsomal stability could be increased while maintaining potent 5-HT2 receptor agonist properties, all analogues had an intrinsic clearance above 1.3 L/kg/h predictive of high first-pass metabolism.

Citations in the library

Explore topics